Ohden Kaitlyn L, Pitz Susanne, Ashworth Jane, Magalhães Augusto, Marinho Diane R, Lindahl Päivi, Teär Fahnehjelm Kristina, Summers C Gail
Medical School, University of Minnesota, Minneapolis, Minnesota, USA.
Department of Ophthalmology, University Medical Center, Johnannes Gutenberg-University, Mainz, Germany.
Br J Ophthalmol. 2017 Jul;101(7):909-912. doi: 10.1136/bjophthalmol-2016-308807. Epub 2016 Sep 28.
To describe visual outcomes after penetrating keratoplasty and deep anterior lamellar keratoplasty in patients with mucopolysaccharidoses.
This is a retrospective review of keratoplasty in consecutive patients from Brazil, England, Finland, Germany, Portugal, Sweden and the USA. All patients had corneal clouding due to mucopolysaccharidoses. Preoperative and postoperative visual outcome and ocular comorbidities were identified. Success was arbitrarily defined as any improvement in visual acuity or best-corrected visual acuity better than logarithm of the minimum angle of resolution 0.30 (20/40). Statistical analysis included only data from first operated eyes in the 16 patients who underwent bilateral keratoplasty.
Forty-eight eyes from 32 patients with mucopolysaccharidoses I, IV or VI are reported. Mean follow-up was 70 months (range: 5-186). Penetrating keratoplasty was performed in 45 eyes and deep anterior lamellar keratoplasty in 3 eyes. At last follow-up, a successful visual outcome for penetrating keratoplasty in first operated/only operated eyes was found in 63%. Rejection episodes occurred in 23% of grafts; however, a clear graft was recorded at last follow-up in 94%. Ocular pathway comorbidities were identified in 63% of eyes transplanted.
Clear corneal grafts can be obtained for patients with corneal clouding due to mucopolysaccharidosis with improvement in visual acuity in the majority.
描述黏多糖贮积症患者穿透性角膜移植术和深板层角膜移植术后的视力结果。
这是一项对来自巴西、英国、芬兰、德国、葡萄牙、瑞典和美国的连续患者进行角膜移植术的回顾性研究。所有患者均因黏多糖贮积症导致角膜混浊。确定术前和术后的视力结果及眼部合并症。成功被任意定义为视力或最佳矫正视力有任何改善,且优于最小分辨角对数0.30(20/40)。统计分析仅包括16例接受双眼角膜移植术患者中首次手术眼的数据。
报告了32例黏多糖贮积症I、IV或VI患者的48只眼。平均随访时间为70个月(范围:5 - 186个月)。45只眼行穿透性角膜移植术,3只眼行深板层角膜移植术。在最后一次随访时,首次手术/仅接受手术的眼中,穿透性角膜移植术获得成功视力结果的比例为63%。23%的移植物发生排斥反应;然而,在最后一次随访时,94%的移植物记录为清亮。63%接受移植的眼中发现有眼部通路合并症。
对于因黏多糖贮积症导致角膜混浊的患者,大多数可获得清亮的角膜移植物,视力得到改善。